| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233559.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039745043 |
Resistant |
| ENSG00000233559.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019319983 |
Resistant |
| ENSG00000233559.1 |
Ponatinib |
Breast invasive carcinoma |
0.015231331 |
Sensitive |
| ENSG00000233559.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046552868 |
Resistant |
